Pfizer COVID-19 Antiviral Pill Paxlovid Reduced Hospitalization, Mortality

Pfizer says its antiviral pill Paxlovid reduced the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adults with COVID-19.